About Xantis Pharma
Xantis Pharma is a company based in Zug (Switzerland) founded in 2015. Xantis Pharma has completed 2 acquisitions, including ALSI Pharma and IPS Middle East. Xantis Pharma offers products and services including Pharmaceutical Treatments and Treatment Solutions. Xantis Pharma operates in a competitive market with competitors including AmerisourceBergen, DCS Pharma, RUWAG, Globomedica and Akenco Pharma, among others.
- Headquarter Zug, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Xantis Pharma Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
ALSI Pharma
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Xantis Pharma
Xantis Pharma offers a comprehensive portfolio of products and services, including Pharmaceutical Treatments and Treatment Solutions.
Offers safe and affordable medical treatments for consumers.
Provides fairly priced options for health and wellness needs.
Funding Insights of Xantis Pharma
Detailed funding history for Xantis Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Xantis Pharma
Xantis Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include ALSI Pharma and IPS Middle East.
Investment portfolio details for Xantis Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Generic finished formulations are manufactured for various therapeutic categories.
|
Locked | Locked | 2012 | Locked | |
|
North Sea natural gas exploration and production are emphasized.
|
Locked | Locked | 2000 | Locked |
Complete acquisition details for Xantis Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Xantis Pharma
Detailed financials for Xantis Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Xantis Pharma Comparisons
Peer comparison for Xantis Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Xantis Pharma
Xantis Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, DCS Pharma, RUWAG, Globomedica and Akenco Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| Locked | Locked | Locked |
Pharmaceutical products are distributed by DCS Pharma in Switzerland.
|
|
| Locked | Locked | Locked |
Distributor of drugs
|
|
| Locked | Locked | Locked |
Diversified pharmaceutical drugs are distributed by Globomedica in Switzerland.
|
|
| Locked | Locked | Locked |
Serves as a diversified distributor in the healthcare sector.
|
Detailed competitors of Xantis Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Xantis Pharma
Complete news archive for Xantis Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xantis Pharma
Xantis Pharma was founded in 2015.
Xantis Pharma is headquartered in Zug, Switzerland. It is registered at Zug, Zug, Switzerland.
Tim Oreskovic is the current CEO of Xantis Pharma.
Xantis Pharma distributor of generic prescription and over-the-counter products through providing healthcare solutions, pharmaceutical distributors, and diversified. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Xantis Pharma's top competitors include AmerisourceBergen, DCS Pharma and RUWAG.
Xantis Pharma offers Pharmaceutical Treatments and Treatment Solutions.
Xantis Pharma has made 2 acquisitions, including ALSI Pharma, and IPS Middle East.